Train as an angel investor on real deals — build investment memos, sit in on due diligence, and earn co-investment rights before you write your first solo check.
12+
Live DD Rotations
$25K
Co-Invest Reserve
200+
LP Syndicate Network
Deal #204 · AI Diagnostic Venture
Predicate device identified with 94% predicate match score. Verified by IGVP FDA Council.
Co-Investment Allocation Unlocked
$25K SAFE co-investment slot reserved for Trainee Analyst
Transition from theoretical investing books to participating in live due diligence & syndicate deals
You want to break into venture investing, but no one lets you practice on real deals — courses teach frameworks, not judgment, and you have zero track record to join a syndicate.
Common Obstacles & Bottlenecks:
Online venture courses only analyze 10-year-old case studies.
No access to deal flow or check-writing reserves in early-stage rounds.
No direct feedback from active GP partners on due diligence memos.
IGVP's 'Angel-in-Training' Syndicate pairs you directly with Accelerator founders to build live investment memos and run real due diligence, turning theory into a portfolio.
IGVP System Advantages:
Hands-on due diligence rotations on active healthtech seed applications.
Guaranteed $25K-$50K SAFE allocation reserves on top syndicate deals.
Direct feedback from IGVP Venture Partners on your investment memos.
Program Deliverables
Participate in real diligence calls, tech stack teardowns, and cap table audits for active deal flow.
Guaranteed allocation rights alongside IGVP Bio Fund in vetted cross-border rounds.
Weekly live teardowns of investment memos, term sheet negotiations, and valuation models.
Direct guidance from experienced GPs on writing investment memos and managing LP syndicates.
Self-segment upon entry into verified channels designed to accelerate co-founder matching, clinical trials, due diligence, and capital deployment.
Angel-in-Training Accreditation Verification
Verified upon syndicate application or portfolio check
Category Channels
Cross-Pollination Engine: Members collide across co-founder matching and deal-flow channels to fuel the Tri-Engine Flywheel.
Just submitted the DD memo for the Indian trial site of Cardio-Sensing #04. Regulatory risk score came back at 88/100!
Great teardown Liam! The CDSCO trial cost reduction makes this valuation very attractive. Participating in the syndicate check.
See how emerging angels and rising syndicate leads co-invest alongside institutional VC funds and achieve outsized portfolio returns.
"As an emerging angel investor, IGVP deal flow is pre-diligenced with clinical validation. My syndicate conversion rate tripled in 6 months."
Elena Kowalski
Syndicate Lead · Emerald Health
12 INVESTMENTS
"I wrote my first $25K healthtech check into an IGVP incubator graduate that went on to raise a $14M Series A backed by top tier VCs."
Marcus Vance
Angel Investor & Tech Executive
4.2X MOIC MARGIN
"The weekly IC memo teardowns on Discord give me institutional-grade due diligence data that would normally require a full analyst team."
Samantha Wu
Managing Partner · NextGen Bio Angels
IC MEMO ACCELERATED
"Co-investing with the IGVP Syndicate gave our angel network access to high-conviction FDA cleared medical device deals."
David H. Park
Principal · Apex Syndicate
$1.8M DEPLOYED
"As an emerging angel investor, IGVP deal flow is pre-diligenced with clinical validation. My syndicate conversion rate tripled in 6 months."
Elena Kowalski
Syndicate Lead · Emerald Health
12 INVESTMENTS
"I wrote my first $25K healthtech check into an IGVP incubator graduate that went on to raise a $14M Series A backed by top tier VCs."
Marcus Vance
Angel Investor & Tech Executive
4.2X MOIC MARGIN
"The weekly IC memo teardowns on Discord give me institutional-grade due diligence data that would normally require a full analyst team."
Samantha Wu
Managing Partner · NextGen Bio Angels
IC MEMO ACCELERATED
"Co-investing with the IGVP Syndicate gave our angel network access to high-conviction FDA cleared medical device deals."
David H. Park
Principal · Apex Syndicate
$1.8M DEPLOYED